scholarly journals Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good's syndrome

2015 ◽  
Vol 48 (2) ◽  
pp. 229-232 ◽  
Author(s):  
Ching-Hsun Wang ◽  
Edward D. Chan ◽  
Cherng-Lih Perng ◽  
Chih-Feng Chian ◽  
Chien-Wen Chen ◽  
...  
2018 ◽  
Vol 2 (2) ◽  
pp. 149-156
Author(s):  
Ana Marija Hošnjak ◽  
Snježana Čukljek ◽  
Sanja Ledinski Fičko ◽  
Martina Smrekar ◽  
Nikolina Veriga ◽  
...  

2002 ◽  
Vol 25 (4) ◽  
pp. 337-343 ◽  
Author(s):  
Hirokazu Kanegane ◽  
Keiko Nomura ◽  
Takeshi Futatani ◽  
Toshio Miyawaki

1993 ◽  
Vol 107 (11) ◽  
pp. 1008-1010 ◽  
Author(s):  
D. G. Snow ◽  
T. T. Hansel ◽  
P. E. Williams ◽  
A. B. Drake-Lee ◽  
R. A. Thompson

AbstractThirteen patients suffering from primary hypogammaglobulinaemia receiving intravenous immunoglobulin replacement therapy underwent computerized tomography of the paranasal sinuses. The CT scans were evaluated and related to clinical data from the patients, who were selected for study on the basis of having symptoms of rhinosinusitis. The scans varied from normal to demonstrating widespread sinus abnormality. Th.ere was no relationship between the scan findings and duration of ENT symptoms, range of current symptoms, or the interval between the onset of ENT symptoms and the start of intravenous immunoglobulin replacement therapy. It is nevertheless possible that prompt institution of replacement therapy, after correct diagnosis early in the course of the disease, may prevent the development of sinus disease refractory to such treatment.


Sign in / Sign up

Export Citation Format

Share Document